Skip to main content

Table 3 Adjusted ORs (95% CI) for the associations between apoB/apoA1 ratio and risk of MetS

From: The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study

  Quartiles of apoB/apoA1 ratio  
Models Q1 (<0.61) Q2 (0.61-0.78) Q3 (0.78-0.98) Q4 (≥0.98) P trend
All subjects      
   Model 1a Reference 1.40 (1.11-1.76) 2.57 (2.07-3.19) 4.30 (3.48-5.32) <0.0001
   Model 2b Reference 1.37 (1.08-1.73) 2.59 (2.08-3.23) 4.28 (3.44-5.31) <0.0001
   Model 3c Reference 1.35 (1.06-1.73) 2.69 (2.13-3.89) 4.24 (3.37-5.32) <0.0001
Men      
   Model 1a Reference 1.04 (0.69-1.57) 1.96 (1.36-2.84) 2.92 (2.05-4.16) <0.0001
   Model 2b Reference 0.98 (0.64-1.48) 1.97 (1.36-2.87) 2.89 (2.01-4.13) <0.0001
   Model 3c Reference 0.94 (0.61-1.45) 1.93 (1.31-2.85) 2.64 (1.82-3.83) <0.0001
Women      
   Model 1a Reference 1.58 (1.19-2.09) 2.74 (2.10-3.58) 4.95 (3.78-6.47) <0.0001
   Model 2b Reference 1.58 (1.19-2.11) 2.79 (2.12-3.66) 4.93 (3.75-6.48) <0.0001
   Model 3c Reference 1.58 (1.17-2.14) 2.99 (2.24-4.00) 5.18 (3.87-6.92) <0.0001
  1. aModel 1 was adjusted by age, gender and BMI.
  2. bbased on Model 1, Model 2 was additionally adjusted by smoking, drinking, urbanization index, educational levels, dietary energy intake everyday, gross household income per year.
  3. cbased on Model 2, Model 3 was additionally adjusted by history of CVD, hypertension, diabetes.